Further benefits by early start of HIV treatment in low income countries: Survival estimates of early versus deferred antiretroviral therapy

BACKGROUND: International HIV guidelines have recently shifted from a medium-late to an early-start treatment strategy. As a consequence, more people will be eligible to Highly Active Antiretroviral Therapy (HAART). We estimate mean life years gained using different treatment indications in low inco...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Kjell Arne, Robberstad, Bjarne, Norheim, Ole Frithjof
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836271/
https://www.ncbi.nlm.nih.gov/pubmed/20180966
http://dx.doi.org/10.1186/1742-6405-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836271/
https://www.ncbi.nlm.nih.gov/pubmed/20180966
http://dx.doi.org/10.1186/1742-6405-7-3

Ejemplares similares